Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia

  • STATUS
    Recruiting
  • End date
    Dec 31, 2022
  • participants needed
    272
  • sponsor
    AbbVie
Updated on 22 September 2021
lymphoid leukemia
chronic lymphocytic leukemia
venetoclax

Summary

This study will evaluate real-life effectiveness and use in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).

Details
Condition Chronic Lymphocytic Leukemia, Lymphocytic Leukemia, Chronic, Cancer - Chronic Lymphocytic Leukemia, leukemia chronic lymphocytic, chronic lymphocytic leukemia (cll), small lymphocytic lymphoma, Cancer - Chronic Lymphocytic Leukemia, Cancer - Chronic Lymphocytic Leukemia, Cancer - Chronic Lymphocytic Leukemia
Clinical Study IdentifierNCT03415035
SponsorAbbVie
Last Modified on22 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Participants with diagnosed Chronic Lymphocytic Leukemia (CLL) and eligible for venetoclax as per label
Participants for whom the physician has decided to initiate CLL treatment with venetoclax
Participants the physician believes he can personally follow over all the study period
Participants who have been informed verbally and in writing about this study, and who do not object to their data being electronically processed or subjected to data quality control

Exclusion Criteria

Participating in a clinical trial with an investigative drug for CLL within 30 days prior to treatment initiation
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note